Form 4: Dolby Laboratories CEO Kevin Yeaman Executes Pre-Planned Stock Option Exercise and Share Sale

Dolby Laboratories President and CEO Kevin J. Yeaman engaged in a pre-scheduled transaction on June 10, 2025, exercising stock options and simultaneously selling an equivalent number of shares through a family trust.

Summary

• Kevin J. Yeaman, President and CEO of Dolby Laboratories, Inc. (DLB), executed a series of transactions on June 10, 2025, under a Rule 10b5-1 plan.
• He exercised employee stock options to acquire a total of 33,683 shares of Class A Common Stock.
• This included 25,000 shares at an exercise price of $45.5 per share and 8,683 shares at an exercise price of $64.6 per share.
• Concurrently, Mr. Yeaman sold 33,683 shares of Class A Common Stock through the Kevin and Rachel Yeaman Family Trust.
• The shares were sold at weighted average prices of $76.223 for 33,504 shares and $76.57 for 179 shares.
• Following these transactions, Mr. Yeaman's indirect beneficial ownership through the trust is 114,725 shares.
• He also holds 127,735 shares directly, underlying restricted stock units, and 2.5592 shares indirectly through a son.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While there's a sale of shares, it's a pre-planned transaction (10b5-1) often used for tax and liquidity purposes following option exercise, rather than a discretionary sale indicating a lack of confidence. The exercise of options at lower prices reflects past stock appreciation.

Positives

• The transactions were made pursuant to a Rule 10b5-1 plan, indicating a pre-scheduled and non-discretionary sale, which typically reduces concerns about opportunistic selling.
• The exercise of options at lower prices ($45.5 and $64.6) compared to the sale prices ($76.223 and $76.57) reflects past stock price appreciation, benefiting the executive.

Negatives

• The sale of 33,683 shares by a key executive, even if pre-planned, represents a reduction in direct equity holdings from the exercised options.

Future Outlook

NA

Industry Context

NA

Related Party Transactions

• The transactions were conducted through the Kevin and Rachel Yeaman Family Trust, which is a related party to the reporting person.

Stakeholder Impact

• Shareholders may observe a reduction in the direct equity holdings of the CEO from the exercised options, though this is offset by the pre-planned nature of the transaction and continued significant indirect holdings.

Key Dates

Recommendation

Keywords

Dolby Laboratories, DLB, Kevin Yeaman, Insider Trading, Form 4, Stock Option Exercise, Share Sale, 10b5-1 Plan, Executive Compensation, Beneficial Ownership